HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 60.20
-0.10 (-0.17%)
Jan 21, 2026, 1:59 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.77 billion as of January 21, 2026. Its market cap has decreased by -12.50% in one year.
Market Cap
2.77B
Enterprise Value
2.31B
Revenue
290.83M
Ranking
n/a
PE Ratio
24.67
Stock Price
60.20
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.77B, a decrease of -33.41%. That is a compound annual growth rate of -15.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.77B | -4.44% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.36B |
| SYN-TECH Chem. & Pharm. | 3.23B |
| GlycoNex Incorporation | 3.14B |
| Synbio Tech | 3.01B |
| Apex Biotechnology | 2.95B |
| G&E Herbal Biotechnology | 2.63B |
| Sunny Pharmtech | 2.53B |
| Sinew Pharma | 2.49B |